Appellate Practice
Feb. 23, 2001
U.S. SUPREME COURT HIGHLIGHTS
Among actions announced Wednesday, Feb. 21, 2001 by the justices were:
FEDERAL PRE-EMPTION: The court ruled unanimously that plaintiffs who allege a manufacturer committed fraud to win Food and Drug Administration approval for its medical device may not bring a state-law tort suit against the manufacturer. Such suits are pre-empted by the Federal Food, Drug and Cosmetic Act, as amended by the Medical Device...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In